novo nordisk oral semaglutide Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment Novo Nordisk announces positive results

Tang, Sarah Al-Saad, Shriya Kamlapurkar, Sierra R

BrandShield, a cybersecurity firm that detects trademark infringement and counterfeit sales online, said on Monday that it shut down more than 250 websites that were hawking fake weight loss drugs.

WTROBA (MASLD/MASH) Semaglutyd uzyska w sierpniu 2025 przyspieszone zatwierdzenie FDA do leczenia stuszczeniowego zapalenia wtroby (MASH) z umiarkowanym lub zaawansowanym wknieniem (badanie ESSENCE)

Evaluate the drug in the context of all its effects

Yildiz BO, Knochenhauer ES, Azziz R

For example, intranasal exenatide achieves high hippocampal concentrations and improves cognitive outcomes in preclinical Alzheimer's models [8,31,32]